In line with previous reports [26], the serum levels of IL-6 and CXCL8 were not significantly elevated among AP and RP patients, as opposed to higher levels observed in metastatic melanoma patients, similar to previously reports [27, 28] (Figure 1). Here, CXCL8 is linked to metastatic melanoma.